Ovid Therapeutics Inc. (OVID)
0.75
0.02 (3.04%)
At close: Jan 29, 2025, 3:59 PM
0.78
4.00%
After-hours Jan 29, 2025, 07:05 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Net Income | -52.34M | -54.17M | 122.83M | -81.04M | -60.46M | -51.98M | -64.81M | -22.41M | -13.16M | -446.89K |
| Depreciation & Amortization | 1.60M | 1.38M | 237.08K | 306.85K | 255.00K | 141.73K | 80.31K | 56.51K | 11.78K | 2.31K |
| Stock-Based Compensation | 7.29M | 6.56M | 5.05M | 7.53M | 5.21M | 7.06M | 6.40M | 3.64M | 1.46M | 33.09K |
| Other Working Capital | 635.51K | -3.06M | -18.52M | 19.49M | 4.59M | -2.44M | -79.50K | 727.78K | 1.22M | 44.69K |
| Other Non-Cash Items | -4.71M | -764.94K | 7.30M | -199.41K | -29.63K | -1.24K | 25.86M | 3.64M | 4.39M | 105.52K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 4.61K | n/a | -3.64M | n/a | n/a |
| Change in Working Capital | 2.39M | -8.23M | -16.81M | 21.82M | 3.94M | -787.91K | 996.85K | 914.40K | 1.81M | 44.69K |
| Operating Cash Flow | -45.78M | -55.23M | 118.61M | -51.58M | -51.09M | -45.56M | -31.47M | -17.80M | -5.49M | -261.28K |
| Capital Expenditures | -137.46K | -1.42M | -189.41K | -390.68K | -244.04K | -352.02K | -47.39K | -188.99K | -56.33K | -1.78K |
| Acquisitions | -10.00M | -2.50M | -1.63M | 263.44K | 186.89K | 318.15K | n/a | n/a | n/a | n/a |
| Purchase of Investments | -112.44M | -172.96M | -1.63B | -9.96M | -34.80M | -50.01M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 120.00M | 90.00M | 1.64B | 45.00M | 5.00M | 45.00M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -97.15K | -1.00M | -5.40M | -263.44K | -186.89K | -318.15K | -8.48K | -158.62K | -24.25K | -4.33K |
| Investing Cash Flow | -2.58M | -87.88M | -1.82M | 34.65M | -30.04M | -5.36M | -47.39K | -188.99K | -56.33K | -6.12K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 30.54M | 180.66K | 904.08K | 341.04K | 131.90K | 286.14K | -3.05M | -13.67K | 70.64M | 6.73M |
| Financial Cash Flow | 30.54M | 180.66K | 904.08K | 47.07M | 86.54M | 286.14K | 66.70M | -13.67K | 70.64M | 6.73M |
| Net Cash Flow | -17.83M | -142.93M | 117.69M | 30.14M | 5.41M | -50.64M | 35.19M | -18.00M | 65.10M | 6.46M |
| Free Cash Flow | -45.92M | -56.65M | 118.42M | -51.97M | -51.33M | -45.91M | -31.52M | -17.99M | -5.54M | -263.06K |